Trials / Conditions / Beta Thalassemia Major

Beta Thalassemia Major

28 registered clinical trials studyying Beta Thalassemia Major — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial NCT06980662	Ataturk University	N/A
Completed	Iron Accumulation in Erythrocytes in Patients NCT07486531	Ankara City Hospital Bilkent	—
Completed	Elastography vs Iron Regulators in the Diagnosis of Hepatic Fibrosis- Iron Overload in Children With Beta- Tha NCT07153926	Tanta University	—
Recruiting	Inspiratory Muscle Training in Children With Beta Thalasemia NCT06466304	Ahram Canadian University	N/A
Completed	A Safety and Efficacy Study Evaluating CS-101 in Subjects With β-Thalassemia Major NCT06291961	CorrectSequence Therapeutics Co., Ltd	Phase 1
Withdrawn	Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies NCT04776850	M.D. Anderson Cancer Center	EARLY_Phase 1
Completed	ERN-EuroBloodNet Registry on Patients With Rare Red Blood Cell Defects and COVID-19 NCT06831799	Hospital Universitari Vall d'Hebron Research Institute	—
Completed	Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation NCT04092205	EmeraMed	Phase 2
Recruiting	T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias NCT03653338	Paul Szabolcs	Phase 1 / Phase 2
Unknown	PK of SOF/LED in HCV - Infected Adolescents With Haematological Disorders NCT04353986	Ain Shams University	Phase 3
Unknown	Gene Therapy for Beta-Thalassemia Major Using Autologous Hematopoietic Stem Cell Genetically Modified NCT03276455	Nanfang Hospital, Southern Medical University	Phase 1 / Phase 2
Unknown	Monitoring of Chimerism After Transplantation in Patients With β Thalassemia Major and the Treatment Strategie NCT03101423	First Affiliated Hospital of Guangxi Medical University	N/A
Completed	Effect of Spirulina on Liver Fibrosis by Transient Elastography in Beta Thalassemic Children With Hepatitis C NCT02744105	Tanta University	N/A
Completed	Effect of Spirulina on Serum Hyaluronic Acid in Beta Thalassemic Children With Hepatitis C NCT02744547	Tanta University	N/A
Completed	the Potential Immunomodulatory Effects of Spirulina on Thalassemic Children NCT02674607	Tanta University	N/A
Completed	Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta Thalassemia NCT02671695	Tanta University	N/A
Completed	Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoi NCT02342145	Zhongming Zhang	Phase 4
Completed	Effect of Spirulina on Liver Iron Concentration in Beta Thalassemic Children With Hepatitis C NCT02744560	Tanta University	N/A
Unknown	An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major Patients NCT02173951	Ain Shams University	Phase 2 / Phase 3
Completed	A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Refe NCT02151526	Genetix Biotherapeutics Inc.	Phase 1 / Phase 2
Completed	Anthropometric Measurements in Children Having Transfusion-dependent Beta Thalassemia NCT03947632	Aga Khan University	—
Terminated	Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. NCT01571635	Celgene	Phase 2
Unknown	Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In C NCT01511848	Ain Shams University	Phase 2 / Phase 3
Unknown	Therapeutic Effects of Silymarin in Patients With B-thalassemia Major NCT00999349	Isfahan University of Medical Sciences	Phase 2 / Phase 3
Completed	HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity NCT02435901	Northwell Health	Phase 1 / Phase 2
Completed	Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hemato NCT00658385	Memorial Sloan Kettering Cancer Center	N/A
Completed	Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia Patients NCT02198508	China Medical University Hospital	N/A
Completed	Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfus NCT00171301	Novartis Pharmaceuticals	Phase 4